Drug Channels Archive for December, 2020

Click a link below to view the mailing archive as if it had been sent to you.

2020-12-18 07:38Drug Channels - Specialty Pharmacy Keeps Disrupting Buy-and-Bill—and COVID-19 Will Accelerate It (rerun)
2020-12-17 07:41Drug Channels - The Booming Biosimilar Market of 2020 (rerun)
2020-12-16 07:46Drug Channels - My Wall Street Journal Op-Ed about the 340B Program (rerun)
2020-12-15 07:51Drug Channels - How GoodRx Profits from Our Broken Pharmacy Pricing System (rerun)
2020-12-14 07:41Drug Channels - Prime Therapeutics Deepens Its Reliance on Express Scripts: Our Four Takeaways From Their New Pharmacy Relationship (rerun)
2020-12-11 07:36Drug Channels - How Real-World Data is Helping Speed Oncology Drug Development
2020-12-10 07:32Drug Channels News Roundup, December 2020: 340B Pharmacy Profits, Pre-Amazon PillPack, Physicians vs. Accumulators, Maine's Importation Fail, and Vaccine Humor
2020-12-09 07:36Join me next week for the Drug Channels Outlook 2021
2020-12-08 07:59Drug Channels - Drug Pricing Policy in 2021: Four Crucial Consequences of Pharmacy Benefits Today
2020-12-01 07:15Drug Channels - Six Crucial Trends Facing U.S. Drug Wholesalers


<< Archive IndexSubscribe >>